Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

US Patent 11771752 · Granted Oct 3, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Complex of botulinum neurotoxin E and its binding protein as a formulation with 2025
Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vac2025
Tetanus vaccine platform for embedding COVID-19 vaccine2025
Complex of botulinum neurotoxin E and its binding protein as a formulation with 2024
Pharmaceutical composition for treating cancer2022
Botulinum neurotoxin compositions2021
Biologically active hemagglutinin from type a Clostridium botulinum and methods 2015
Methods of identifying a compound that increases or decreases the interaction of2014
Detoxified recombinant botulinum neurotoxin2013
Proteins within the type E botulinum neurotoxin complex2011
Stabilization of Clostridium botulinum neurotoxin complex2010
Biologically active hemagglutinin from type A Clostridium botulinum and methods 2009